Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Context. Blood pressure control (<140/90 mm Hg) rates for hypertension fall far short of the US national goal of 50% or more. Achievable control rates in varied practice settings and geographic regions and factors that predict improved blood pressure control are not well identified.

[1]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[2]  B. Davis,et al.  The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. , 2001, Controlled clinical trials.

[3]  V. Pavlik,et al.  Characteristics of patients with uncontrolled hypertension in the United States. , 2001, The New England journal of medicine.

[4]  S S Franklin,et al.  Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives: Analysis Based on National Health and Nutrition Examination Survey (NHANES) III , 2001, Hypertension.

[5]  P. Grambsch,et al.  Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial , 2001, Hypertension.

[6]  W. Cushman,et al.  Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2001, Hypertension.

[7]  B. Davis,et al.  Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 1998, Controlled clinical trials.

[8]  M. Nieminen,et al.  Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. , 2000, American journal of hypertension.

[9]  S. Julius.  Worldwide trends and shortcomings in the treatment of hypertension. , 2000, American journal of hypertension.

[10]  Barry R. Davis,et al.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. , 2000, JAMA.

[11]  D. Reda,et al.  Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 2000, Archives of internal medicine.

[12]  K. Bailey,et al.  Detection and control of high blood pressure in the community : Do we need a wake-up call? , 1999, Hypertension.

[13]  M. Moser.  A critique of the world health organization-international society of hypertension guidelines for the management of hypertension , 1999 .

[14]  H. Ward,et al.  Inadequate management of blood pressure in a hypertensive population. , 1999, New England Journal of Medicine.

[15]  Michael A. Proschan,et al.  Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 1996 .

[16]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[17]  M. Wahlqvist,et al.  Doppler Ultrasound Recognition of Preclinical Changes in Arterial Wall in Diabetic Subjects: Compliance and Pulse-Wave Damping , 1986, Diabetes Care.

[18]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .